Neuronetics (STIM) Debt Ratio (2017 - 2026)
Neuronetics (STIM) reported Debt Ratio of 0.49 for Q1 2026, up 23.65% year-over-year from 0.4 in Q1 2025, and up 4.74% on a QoQ basis from 0.47 in Q4 2025.
Neuronetics (STIM) has 10 years of Debt Ratio data on file, last reported at 0.49 in Q1 2026.
- Quarterly Debt Ratio rose 23.65% year-over-year to 0.49 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.49 (up 23.65% YoY) and the FY2025 annual result came in at 0.47, up 17.55% from the prior year.
- Debt Ratio climbed to 0.49 in Q1 2026 per STIM's latest filing, from 0.47 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.62 in Q3 2024 and bottomed at 0.27 in Q1 2022.
- The 5-year median for Debt Ratio is 0.4 (2024), against an average of 0.43.
- The widest annual swing landed in 2024, when Debt Ratio jumped 68.79%; it then tumbled 31.97% in 2025.
- Tracing STIM's Debt Ratio over 5 years: stood at 0.31 in 2022, then jumped by 66.38% to 0.51 in 2023, then slipped by 22.14% to 0.4 in 2024, then rose by 17.55% to 0.47 in 2025, then grew by 4.74% to 0.49 in 2026.
- Per Business Quant, the three latest STIM Debt Ratio figures stand at 0.49 (Q1 2026), 0.47 (Q4 2025), and 0.46 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 0.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.49 |
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.46 |
| Jun 30, 2025 | 0.42 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.62 |
| Jun 30, 2024 | 0.62 |
| Mar 31, 2024 | 0.57 |
| Dec 31, 2023 | 0.51 |
| Sep 30, 2023 | 0.40 |
| Jun 30, 2023 | 0.37 |
| Mar 31, 2023 | 0.35 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.29 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | 0.25 |
| Sep 30, 2021 | 0.25 |
| Jun 30, 2021 | 0.24 |
| Mar 31, 2021 | 0.23 |
| Dec 31, 2020 | 0.44 |
| Sep 30, 2020 | 0.44 |
| Jun 30, 2020 | 0.43 |
| Mar 31, 2020 | 0.39 |
| Dec 31, 2019 | 0.31 |
| Sep 30, 2019 | 0.29 |
| Jun 30, 2019 | 0.28 |
| Mar 31, 2019 | 0.27 |
| Dec 31, 2018 | 0.26 |
| Sep 30, 2018 | 0.25 |
| Jun 30, 2018 | 1.06 |
| Dec 31, 2017 | 0.76 |